Progress in antiangiogenic gene therapy
β
Andrew L. Feldman; Steven K. Libutti
π
Article
π
2000
π
John Wiley and Sons
π
English
β 145 KB
π 2 views
## BACKGROUND. Because tumors require angiogenesis for growth, inhibiting angiogenesis is a promising strategy for treating cancer patients. Although numerous endogenous angiogenesis inhibitors have been discovered, the clinical evaluation of these agents has been hindered by high dose requirement